LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
KARA SEALOCK
4th Edition
TEST BANK
, lOMoAR cPSD| 3013804
lOMoAR cPSD| 3013804
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
ANS: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to sw
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
ANS: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and h
of possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
ANS: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which st
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
ANS: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable o
instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatmen
and would be difficult to measure.
DIF: Cognitive Level: Application
, lOMoAR cPSD| 3013804
6. The nurse is working during a very busy night shift, and the health care provider has just given the nurs
the telephone, but the nurse does not recall the route. What is the best way for the nurse to avoid medic
a. Recopy the order neatly on the order sheet, with the most common route indicated
b. Consult with the pharmacist for clarification about the most common route
c. Call the health care provider to clarify the route of administration
d. Withhold the drug until the health care provider visits the patient
ANS: C
If a medication order does not include the route, the nurse must ask the health care provider to clarify it
administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
7. Which constitutes the traditional Five Rights of medication administration?
a. Right drug, right route, right dose, right time, and right patient
b. Right drug, the right effect, the right route, the right time, and the right patient
c. Right patient, right strength, right diagnosis, right drug, and right route
d. Right patient, right diagnosis, right drug, right route, and right time
ANS: A
The traditional Five Rights of medication administration were considered to be Right drug, Right route
Right patient. Right effect, right strength, and right diagnosis are not part of the traditional Five Rights
DIF: Cognitive Level: Comprehension
8. What correctly describes the nursing process?
a. Diagnosing, planning, assessing, implementing, and finally evaluating
b. Assessing, then diagnosing, implementing, and ending with evaluating
c. A linear direction that begins with assessing and continues through diagnosing,
planning, and finally implementing
d. An ongoing process that begins with assessing and continues with diagnosing,
planning, implementing, and evaluating
ANS: D
The nursing process is an ongoing, flexible, adaptable, and adjustable five-step process that begins with
through diagnosing, planning, implementing, and finally evaluating, which may then lead back to any o
DIF: Cognitive Level: Application
9. When the nurse is considering the timing of a drug dose, which is most important to assess?
a. The patient’s identification
b. The patient’s weight
c. The patient’s last meal
d. Any drug or food allergies
ANS: C
The pharmacokinetic and pharmacodynamic properties of the drug need to be assessed with regard to a
compatibility issues. The patient’s identification, weight, and drug or food allergies are not affected by
DIF: Cognitive Level: Application
10. The nurse is writing nursing diagnoses for a plan of care. Which reflects the correct format for her nurs
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements such as “I’m upset about having to give myself shots”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to give myself shots”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. The only complete answer is “Anxiet
, lOMoAR cPSD| 3013804
Chapter 02: Pharmacological Principles
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. A dpatient dis dreceiving dtwo ddifferent ddrugs, dwhich, dat dtheir dcurrent ddose dforms dand ddosages, dare d
dcirculation din didentical damounts. dWhich dterm dbest ddenotes dthat dthe ddrugs dhave dthe dsame dabsorp
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: d D
Two ddrugs dabsorbed dinto dthe dcirculation dat dthe dsame damount d(in dspecific ddosage dforms) dhave
dthus, dthey dare dbioequivalent. d“Equivalent” dis dincorrect dbecause dthe dterm d“bioavailability” dis duse
ddrug dabsorption.
“Synergistic” dis dincorrect dbecause dthis dterm drefers dto dtwo ddrugs dgiven dtogether dwhose dresulting
dsum dof dthe deffects dof deach ddrug dgiven dalone. d“Compatible” dis dincorrect dbecause dthis dterm di
dindicate dthat dtwo dsubstances ddo dnot dhave da dchemical dreaction dwhen dmixed d(or dgiven, din dthe dca
DIF: Cognitive dLevel: dComprehension
2. A dpatient dis dreceiving dmedication dvia dintravenous dinjection. dWhich dinformation dshould dthe dnurse
d education?
a. The dmedication dwill dcause dfewer dadverse deffects dwhen dgiven dintravenously.
b. The dmedication dwill dbe dabsorbed dslowly dinto dthe dtissues dover dtime.
c. The dmedication’s daction dwill dbegin dfaster dwhen dgiven dintravenously.
d. Most dof dthe ddrug dis dinactivated dby dthe dliver dbefore dit dreaches dthe dtarget darea.
ANS: d C
Intravenous dinjections dare dthe dfastest droute dof dabsorption. dThe dintravenous droute ddoes dnot daffect
deffects, dthe dintravenous droute dis dnot da dslow droute dof dabsorption, dand dthe dintravenous droute ddoe
dof dthe ddrug dby dthe dliver dbefore dit dreaches dthe dtarget darea.
DIF: Cognitive dLevel: dComprehension
3. Which dis dtrue dregarding dparenteral ddrugs?
a. They dbypass dthe dfirst-pass deffect.
b. They ddecrease dblood dflow dto dthe dstomach.
c. They dare daltered dby dthe dpresence dof dfood din dthe dstomach.
d. They dexert dtheir deffects dwhile dcirculating din dthe dbloodstream.
ANS: d A
Drugs dgiven dby dthe dparenteral droute dbypass dthe dfirst-pass deffect, dbut dthey dstill dmust dbe dabsorbed
dbefore dthey dcan dexert dtheir deffects. dEnteral ddrugs d(drugs dtaken dorally), dnot dparenteral ddrugs, dde
dstomach dand dare d altered dby dthe dpresence dof dfood din dthe dstomach. dParenteral ddrugs dmust dbe dab
dtissues dfrom dthe dcirculation dbefore dthey dcan dexert dtheir deffects; dthey ddo dnot dexert dtheir deffects
dbloodstream.
DIF: Cognitive dLevel: dAnalysis
4. A ddrug’s dhalf-life dis dbest ddefined das
a. The dtime dit dtakes dfor dthe ddrug dto delicit dhalf dits dtherapeutic dresponse.
b. The dtime dit dtakes done-half dof dthe doriginal damount dof da ddrug dto dreach
dthe dtarget dcells.
c. The dtime dit dtakes done-half dof dthe doriginal damount dof da ddrug dto dbe dremoved
dfrom dthe dbody.
d. The dtime dit dtakes done-half dof dthe doriginal damount dof da ddrug dto dbe dabsorbed
dinto dthe dcirculation.